RxSight Inc
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
RXST$4.86+7.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(In thousands, except share and per share amounts)
| December 31, | December 31, | |
|---|---|---|
| 2023 | 2022 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $9,692 | $11,834 |
| Short-term investments | 117,490 | 93,968 |
| Accounts receivable | 20,281 | 10,956 |
| Inventories, net | 17,421 | 14,835 |
| Prepaid and other current assets | 3,523 | 2,962 |
| Total current assets | 168,407 | 134,555 |
| Property and equipment, net | 10,841 | 10,138 |
| Operating leases right-of-use assets | 2,444 | 3,943 |
| Restricted cash | 711 | 761 |
| Other assets | 147 | 767 |
| Total assets | $182,550 | $150,164 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $3,863 | $2,595 |
| Accrued expenses and other current liabilities | 15,239 | 12,672 |
| Lease liabilities | 1,801 | 1,970 |
| Total current liabilities | 20,903 | 17,237 |
| Long-term lease liabilities | 1,211 | 2,856 |
| Term loan, net | — | 40,169 |
| Other long-term liabilities | 74 | — |
| Total liabilities | 22,188 | 60,262 |
| Commitments and contingencies (Note 9) | ||
| Stockholders' equity: | ||
| Common stock, $0.001 par value, 900,000,000 shares authorized, 36,139,513 shares issued and outstanding as of December 31, 2023 and 28,268,389 shares issued and outstanding as of December 31, 2022 | 36 | 28 |
| Preferred stock, $0.001 par value, 100,000,000 shares authorized, no shares issued and outstanding | — | — |
| Additional paid-in capital | 754,971 | 636,001 |
| Accumulated other comprehensive loss | (5) | (95) |
| Accumulated deficit | (594,640) | (546,032) |
| Total stockholders' equity | 160,362 | 89,902 |
| Total liabilities and stockholders' equity | $182,550 | $150,164 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.